AM

Alpaben Mukeshbhai Pansuria

Director Director DIN 05320352
DIN 05320352 First appointment Jul 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2012
Shareholding value •••• Premium profile

About Alpaben Mukeshbhai Pansuria

Data last updated:

Alpaben Mukeshbhai Pansuria was a Director at Android Bioscience Private Limited (2012–2016) and Director at Revo Medicare Private Limited (2012–2018). The companies operate in Pharma.

DIN 05320352
Primary Designation Director
Industry Pharma
First Appointment 13 Jul 2012

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Android Bioscience Private Limited U24230GJ2012PTC070654
Director31 Jul 20122012₹1,024 (FY 2025)Active
Revo Medicare Private Limited U24297GJ2012PTC071116
Director13 Jul 20122012Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Android Bioscience Private Limited
Revo Medicare Private Limited
Premium access

Shareholding and investment profile for Alpaben Mukeshbhai Pansuria

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alpaben Mukeshbhai Pansuria

Alpaben Mukeshbhai Pansuria was first appointed on 13 Jul 2012 as Director at Revo Medicare Private Limited.

Alpaben Mukeshbhai Pansuria held 2 earlier board appointments: Android Bioscience Private Limited (Director, 31 Jul 2012 to 25 Nov 2016); Revo Medicare Private Limited (Director, 13 Jul 2012 to 15 Nov 2018).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available